| Year |
Citation |
Score |
| 2023 |
Honnell V, Sweeney S, Norrie J, Ramirez C, Xu B, Teubner B, Lee AY, Bell C, Dyer MA. Identification of Evolutionarily Conserved VSX2 Enhancers in Retinal Development. Biorxiv : the Preprint Server For Biology. PMID 37905144 DOI: 10.1101/2023.10.17.562742 |
0.392 |
|
| 2023 |
Norrie JL, Lupo M, Shirinifard A, Djekidel N, Ramirez C, Xu B, Dundee JM, Dyer MA. Latent Epigenetic Programs in Müller Glia Contribute to Stress, Injury, and Disease Response in the Retina. Biorxiv : the Preprint Server For Biology. PMID 37905050 DOI: 10.1101/2023.10.15.562396 |
0.354 |
|
| 2022 |
Whitney IE, Butrus S, Dyer MA, Rieke F, Sanes JR, Shekhar K. Vision-Dependent and -Independent Molecular Maturation of Mouse Retinal Ganglion Cells. Neuroscience. PMID 35870562 DOI: 10.1016/j.neuroscience.2022.07.013 |
0.333 |
|
| 2022 |
Van Gelder RN, Chiang MF, Dyer MA, Greenwell TN, Levin LA, Wong RO, Svendsen CN. Regenerative and restorative medicine for eye disease. Nature Medicine. 28: 1149-1156. PMID 35715505 DOI: 10.1038/s41591-022-01862-8 |
0.331 |
|
| 2022 |
Honnell V, Norrie JL, Patel AG, Ramirez C, Zhang J, Lai YH, Wan S, Dyer MA. Identification of a modular super-enhancer in murine retinal development. Nature Communications. 13: 253. PMID 35017532 DOI: 10.1038/s41467-021-27924-y |
0.801 |
|
| 2021 |
Norrie JL, Nityanandam A, Lai K, Chen X, Wilson M, Stewart E, Griffiths L, Jin H, Wu G, Orr B, Tran Q, Allen S, Reilly C, Zhou X, Zhang J, ... ... Dyer MA, et al. Retinoblastoma from human stem cell-derived retinal organoids. Nature Communications. 12: 4535. PMID 34315877 DOI: 10.1038/s41467-021-24781-7 |
0.359 |
|
| 2020 |
Nguyen R, Patel AG, Griffiths LM, Dapper J, Stewart EA, Houston J, Johnson M, Akers WJ, Furman WL, Dyer MA. Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastoma. Cancer Immunology, Immunotherapy : Cii. PMID 32915319 DOI: 10.1007/S00262-020-02713-6 |
0.442 |
|
| 2020 |
Slyper M, Porter CBM, Ashenberg O, Waldman J, Drokhlyansky E, Wakiro I, Smillie C, Smith-Rosario G, Wu J, Dionne D, Vigneau S, Jané-Valbuena J, Tickle TL, Napolitano S, Su MJ, ... ... Dyer MA, et al. Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nature Medicine. PMID 32587393 DOI: 10.1038/S41591-020-0976-3 |
0.311 |
|
| 2020 |
Slyper M, Porter CBM, Ashenberg O, Waldman J, Drokhlyansky E, Wakiro I, Smillie C, Smith-Rosario G, Wu J, Dionne D, Vigneau S, Jané-Valbuena J, Tickle TL, Napolitano S, Su MJ, ... ... Dyer MA, et al. A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nature Medicine. 26: 792-802. PMID 32405060 DOI: 10.1038/S41591-020-0844-1 |
0.356 |
|
| 2020 |
Zeineldin M, Federico S, Chen X, Fan Y, Xu B, Stewart E, Zhou X, Jeon J, Griffiths L, Nguyen R, Norrie J, Easton J, Mulder H, Yergeau D, Liu Y, ... ... Dyer MA, et al. MYCN amplification and ATRX mutations are incompatible in neuroblastoma. Nature Communications. 11: 913. PMID 32060267 DOI: 10.1038/S41467-020-14682-6 |
0.362 |
|
| 2020 |
Moustaki A, Crawford JC, Alli S, Zamora A, Fan Y, Boi S, McDonald NM, Thomas PG, Pappo AS, Dyer MA, Stewart E, Federico S, Youngblood B. Abstract LB-074: Antigen-cross presentation promotes development of terminally differentiated CD8 T cells in young individuals Cancer Research. 80. DOI: 10.1158/1538-7445.Am2020-Lb-074 |
0.37 |
|
| 2020 |
Dunphy PS, Xu K, Gentry DT, He C, Mercer K, Zhu X, Smith K, Gudenas B, Robinson S, Zhang J, Kasper LH, Kwon C, Hover LD, Larson JD, Twarog N, ... ... Dyer MA, et al. Abstract 6144: St. Jude Pediatric Brain Tumor Portal: Cloud-based resource for patient-derived orthotopic xenograft (PDOX) models of pediatric high-grade glioma, ependymoma, and CNS embryonal tumors Tumor Biology. DOI: 10.1158/1538-7445.Am2020-6144 |
0.303 |
|
| 2019 |
Norrie JL, Lupo MS, Xu B, Al Diri I, Valentine M, Putnam D, Griffiths L, Zhang J, Johnson D, Easton J, Shao Y, Honnell V, Frase S, Miller S, Stewart V, ... ... Dyer MA, et al. Nucleome Dynamics during Retinal Development. Neuron. PMID 31493975 DOI: 10.1016/J.Neuron.2019.08.002 |
0.731 |
|
| 2019 |
Brady SW, Ma X, Bahrami A, Satas G, Wu G, Newman S, Rusch M, Putnam DK, Mulder HL, Yergeau D, Edmonson MN, Easton J, Alexandrov LB, Chen X, Mardis ER, ... ... Dyer MA, et al. The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment. Molecular Cancer Research : McR. PMID 30651371 DOI: 10.1158/1541-7786.Mcr-18-0620 |
0.335 |
|
| 2019 |
Patel AG, Stewart E, Clay M, Chen X, Dyer M. Abstract 3768: Single-cell characterization and lineage tracking of recurrent pediatric rhabdomyosarcoma Cancer Research. 79: 3768-3768. DOI: 10.1158/1538-7445.Am2019-3768 |
0.395 |
|
| 2018 |
Loh A, Bradley C, Karlstrom A, Krafcik F, Dyer MA, Stewart E, Goshorn R, Chen X, Daryani V, Stewart C, Calabrese C, Funk A, Miller G, Shelat A, Bahrami A. Combinatorial Screening Using Orthotopic Patient Derived Xenograft-Expanded Early Phase Cultures of Osteosarcoma Identify Novel Therapeutic Drug Combinations. Cancer Letters. PMID 30395907 DOI: 10.1016/J.Canlet.2018.10.033 |
0.38 |
|
| 2018 |
Stewart E, McEvoy J, Wang H, Chen X, Honnell V, Ocarz M, Gordon B, Dapper J, Blankenship K, Yang Y, Li Y, Shaw TI, Cho JH, Wang X, Xu B, ... ... Dyer MA, et al. Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses. Cancer Cell. PMID 30146332 DOI: 10.1016/J.Ccell.2018.07.012 |
0.773 |
|
| 2018 |
Wang L, Hiler D, Xu B, AlDiri I, Chen X, Zhou X, Griffiths L, Valentine M, Shirinifard A, Sablauer A, Thiagarajan S, Barabas ME, Zhang J, Johnson D, Frase S, ... Dyer MA, et al. Retinal Cell Type DNA Methylation and Histone Modifications Predict Reprogramming Efficiency and Retinogenesis in 3D Organoid Cultures. Cell Reports. 22: 2601-2614. PMID 29514090 DOI: 10.1016/J.Celrep.2018.01.075 |
0.384 |
|
| 2018 |
Nguyen R, Houston J, Chan WK, Finkelstein D, Dyer MA. The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma. Cancer Immunology, Immunotherapy : Cii. PMID 29327110 DOI: 10.1007/s00262-017-2108-6 |
0.371 |
|
| 2018 |
Zeineldin M, Federico SM, Griffith L, Jeon J, Chen X, Easton J, Wu J, Mao S, Liu Y, Naranjo A, Pappo AS, Hogarty MD, Dyer MA. Abstract PR11: Synthetic lethality between ATRX mutations and MYCN amplification in neuroblastoma Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-Pr11 |
0.391 |
|
| 2018 |
Zeineldin M, Federico S, Chen X, Xu B, Stewart E, Naranjo A, Hogarty MD, Dyer MA. Abstract IA18: MYCN amplification and ATRX mutations are incompatible in neuroblastoma Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-Ia18 |
0.346 |
|
| 2017 |
Chang TC, Carter RA, Li Y, Li Y, Wang H, Edmonson MN, Chen X, Arnold P, Geiger TL, Wu G, Peng J, Dyer M, Downing JR, Green DR, Thomas PG, et al. The neoepitope landscape in pediatric cancers. Genome Medicine. 9: 78. PMID 28854978 DOI: 10.1186/S13073-017-0468-3 |
0.337 |
|
| 2017 |
Stewart E, Federico SM, Chen X, Shelat AA, Bradley C, Gordon B, Karlstrom A, Twarog NR, Clay MR, Bahrami A, Freeman BB, Xu B, Zhou X, Wu J, Honnell V, ... ... Dyer MA, et al. Orthotopic patient-derived xenografts of paediatric solid tumours. Nature. PMID 28854174 DOI: 10.1038/Nature23647 |
0.752 |
|
| 2017 |
Aldiri I, Xu B, Wang L, Chen X, Hiler D, Griffiths L, Valentine M, Shirinifard A, Thiagarajan S, Sablauer A, Barabas ME, Zhang J, Johnson D, Frase S, Zhou X, ... ... Dyer MA, et al. The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis. Neuron. 94: 550-568.e10. PMID 28472656 DOI: 10.1016/J.Neuron.2017.04.022 |
0.467 |
|
| 2017 |
Dyer MA, Qadeer ZA, Valle-Garcia D, Bernstein E. ATRX and DAXX: Mechanisms and Mutations. Cold Spring Harbor Perspectives in Medicine. PMID 28062559 DOI: 10.1101/Cshperspect.A026567 |
0.336 |
|
| 2017 |
Stewart E, Honnell V, Ocarz M, Blankenship K, Dapper J, Freeman B, Shelat A, Pappo AS, Dyer MA. Targeting the cell cycle for cancer therapy in rhabdomyosarcoma. Journal of Clinical Oncology. 35: 10535-10535. DOI: 10.1200/Jco.2017.35.15_Suppl.10535 |
0.312 |
|
| 2016 |
Dyer MA. Biomedicine: An eye on retinal recovery. Nature. PMID 27919071 DOI: 10.1038/nature20487 |
0.366 |
|
| 2016 |
Hiler DJ, Barabas ME, Griffiths LM, Dyer MA. Reprogramming of mouse retinal neurons and standardized quantification of their differentiation in 3D retinal cultures. Nature Protocols. 11: 1955-1976. PMID 27658012 DOI: 10.1038/Nprot.2016.109 |
0.436 |
|
| 2016 |
Dyer MA. Lessons from Retinoblastoma: Implications for Cancer, Development, Evolution, and Regenerative Medicine. Trends in Molecular Medicine. PMID 27567287 DOI: 10.1016/j.molmed.2016.07.010 |
0.391 |
|
| 2016 |
Valle-García D, Qadeer ZA, McHugh DS, Ghiraldini FG, Chowdhury AH, Hasson D, Dyer MA, Recillas-Targa F, Bernstein E. ATRX binds to atypical chromatin domains at the 3' exons of zinc finger genes to preserve H3K9me3 enrichment. Epigenetics. 0. PMID 27029610 DOI: 10.1080/15592294.2016.1169351 |
0.35 |
|
| 2016 |
Grace CR, Ban D, Min J, Mayasundari A, Min L, Finch KE, Griffiths L, Bharatham N, Bashford D, Kiplin Guy R, Dyer MA, Kriwacki RW. Monitoring ligand-induced protein ordering in drug discovery. Journal of Molecular Biology. PMID 26812210 DOI: 10.1016/J.Jmb.2016.01.016 |
0.306 |
|
| 2016 |
Dyer M. Abstract IA17: Dynamic changes in the epigenetic landscape during retinal development, cellular reprogramming, and tumorigenesis Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Devbiolca15-Ia17 |
0.488 |
|
| 2016 |
Dyer M. Abstract IA12: Targeting the cell cycle in pediatric solid tumors Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Cellcycle16-Ia12 |
0.407 |
|
| 2016 |
Stewart E, Bradley C, Shelat A, Pappo A, Dyer MA. Abstract A09: Preclinical trial using the combination of panobinostat with bortezomib in human orthotopic xenograft mouse models of rhabdomyosarcoma Cancer Research. 76. DOI: 10.1158/1538-7445.Pedca15-A09 |
0.331 |
|
| 2015 |
Aldiri I, Ajioka I, Xu B, Zhang J, Chen X, Benavente C, Finkelstein D, Johnson D, Akiyama J, Pennacchio LA, Dyer MA. Brg1 coordinates multiple processes during retinogenesis and is a tumor suppressor in retinoblastoma. Development (Cambridge, England). 142: 4092-106. PMID 26628093 DOI: 10.1242/Dev.124800 |
0.806 |
|
| 2015 |
Langenau DM, Sweet-Cordero A, Wechsler-Reya RJ, Dyer MA. Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer. Cancer Research. PMID 26627009 DOI: 10.1158/0008-5472.Can-15-1308 |
0.357 |
|
| 2015 |
McEvoy JD, Dyer MA. Genetic and Epigenetic Discoveries in Human Retinoblastoma. Critical Reviews in Oncogenesis. 20: 217-25. PMID 26349417 DOI: 10.1615/Critrevoncog.2015013711 |
0.419 |
|
| 2015 |
Pritchard EM, Dyer MA, Guy RK. Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma. Mini Reviews in Medicinal Chemistry. PMID 26202204 DOI: 10.2174/1389557515666150722100610 |
0.337 |
|
| 2015 |
Hiler D, Chen X, Hazen J, Kupriyanov S, Carroll PA, Qu C, Xu B, Johnson D, Griffiths L, Frase S, Rodriguez AR, Martin G, Zhang J, Jeon J, Fan Y, ... ... Dyer MA, et al. Quantification of Retinogenesis in 3D Cultures Reveals Epigenetic Memory and Higher Efficiency in iPSCs Derived from Rod Photoreceptors. Cell Stem Cell. 17: 101-115. PMID 26140606 DOI: 10.1016/J.Stem.2015.05.015 |
0.389 |
|
| 2015 |
Stewart E, Federico S, Karlstrom A, Shelat A, Sablauer A, Pappo A, Dyer MA. The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities. Developmental Biology. PMID 26068307 DOI: 10.1016/J.Ydbio.2015.03.001 |
0.379 |
|
| 2015 |
Moriarity BS, Otto GM, Rahrmann EP, Rathe SK, Wolf NK, Weg MT, Manlove LA, LaRue RS, Temiz NA, Molyneux SD, Choi K, Holly KJ, Sarver AL, Scott MC, Forster CL, ... ... Dyer MA, et al. A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. Nature Genetics. 47: 615-24. PMID 25961939 DOI: 10.1038/Ng.3293 |
0.354 |
|
| 2015 |
Stewart E, Federico S, Karlstrom A, Shelat A, Sablauer A, Pappo A, Dyer MA. The childhood solid tumor network: A new resource for the developmental biology and oncology research communities. Developmental Biology. PMID 25863122 DOI: 10.1016/J.Ydbio.2015.02.002 |
0.404 |
|
| 2015 |
Gupte A, Baker EK, Wan SS, Stewart E, Loh A, Shelat AA, Gould CM, Chalk AM, Taylor S, Lackovic K, Karlström Å, Mutsaers AJ, Desai J, Madhamshettiwar PB, Zannettino AC, ... ... Dyer MA, et al. Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3216-29. PMID 25862761 DOI: 10.1158/1078-0432.Ccr-14-3026 |
0.337 |
|
| 2015 |
Pinto EM, Chen X, Easton J, Finkelstein D, Liu Z, Pounds S, Rodriguez-Galindo C, Lund TC, Mardis ER, Wilson RK, Boggs K, Yergeau D, Cheng J, Mulder HL, Manne J, ... ... Dyer MA, et al. Genomic landscape of paediatric adrenocortical tumours. Nature Communications. 6: 6302. PMID 25743702 DOI: 10.1038/ncomms7302 |
0.336 |
|
| 2015 |
Chen X, Pappo A, Dyer MA. Pediatric solid tumor genomics and developmental pliancy. Oncogene. PMID 25639868 DOI: 10.1038/onc.2014.474 |
0.38 |
|
| 2015 |
Benavente CA, Dyer MA. Genetically engineered mouse and orthotopic human tumor xenograft models of retinoblastoma. Methods in Molecular Biology (Clifton, N.J.). 1267: 307-17. PMID 25636476 DOI: 10.1007/978-1-4939-2297-0_15 |
0.758 |
|
| 2015 |
Benavente CA, Dyer MA. Genetics and epigenetics of human retinoblastoma. Annual Review of Pathology. 10: 547-62. PMID 25621664 DOI: 10.1146/annurev-pathol-012414-040259 |
0.769 |
|
| 2015 |
Lu C, Zhang J, Nagahawatte P, Easton J, Lee S, Liu Z, Ding L, Wyczalkowski MA, Valentine M, Navid F, Mulder H, Tatevossian RG, Dalton J, Davenport J, Yin Z, ... ... Dyer M, et al. The genomic landscape of childhood and adolescent melanoma. The Journal of Investigative Dermatology. 135: 816-23. PMID 25268584 DOI: 10.1038/Jid.2014.425 |
0.326 |
|
| 2015 |
Bahrami A, Wu J, Dyer MA, Delattre O, Pappo AS. Loss of STAG2 expression and prognosis in Ewing sarcoma family of tumors. Journal of Clinical Oncology. 33: 10024-10024. DOI: 10.1200/JCO.2015.33.15_SUPPL.10024 |
0.305 |
|
| 2014 |
Stewart E, Goshorn R, Bradley C, Griffiths LM, Benavente C, Twarog NR, Miller GM, Caufield W, Freeman BB, Bahrami A, Pappo A, Wu J, Loh A, Karlström Å, Calabrese C, ... ... Dyer MA, et al. Targeting the DNA repair pathway in Ewing sarcoma. Cell Reports. 9: 829-41. PMID 25437539 DOI: 10.1016/J.Celrep.2014.09.028 |
0.747 |
|
| 2014 |
Benavente CA, Finkelstein D, Johnson DA, Marine JC, Ashery-Padan R, Dyer MA. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression. Oncotarget. 5: 9594-608. PMID 25338120 DOI: 10.18632/Oncotarget.2468 |
0.787 |
|
| 2014 |
Tirode F, Surdez D, Ma X, Parker M, Le Deley MC, Bahrami A, Zhang Z, Lapouble E, Grossetête-Lalami S, Rusch M, Reynaud S, Rio-Frio T, Hedlund E, Wu G, Chen X, ... ... Dyer M, et al. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discovery. 4: 1342-53. PMID 25223734 DOI: 10.1158/2159-8290.Cd-14-0622 |
0.363 |
|
| 2014 |
Miles WO, Korenjak M, Griffiths LM, Dyer MA, Provero P, Dyson NJ. Post-transcriptional gene expression control by NANOS is up-regulated and functionally important in pRb-deficient cells. The Embo Journal. 33: 2201-15. PMID 25100735 DOI: 10.15252/Embj.201488057 |
0.443 |
|
| 2014 |
Valle-García D, Griffiths LM, Dyer MA, Bernstein E, Recillas-Targa F. The ATRX cDNA is prone to bacterial IS10 element insertions that alter its structure. Springerplus. 3: 222. PMID 24834375 DOI: 10.1186/2193-1801-3-222 |
0.317 |
|
| 2014 |
McEvoy J, Nagahawatte P, Finkelstein D, Richards-Yutz J, Valentine M, Ma J, Mullighan C, Song G, Chen X, Wilson M, Brennan R, Pounds S, Becksfort J, Huether R, Lu C, ... ... Dyer MA, et al. RB1 gene inactivation by chromothripsis in human retinoblastoma. Oncotarget. 5: 438-50. PMID 24509483 DOI: 10.18632/Oncotarget.1686 |
0.32 |
|
| 2014 |
Zhang H, Nieves JL, Fraser ST, Isern J, Douvaras P, Papatsenko D, D'Souza SL, Lemischka IR, Dyer MA, Baron MH. Expression of podocalyxin separates the hematopoietic and vascular potentials of mouse embryonic stem cell-derived mesoderm. Stem Cells (Dayton, Ohio). 32: 191-203. PMID 24022884 DOI: 10.1002/Stem.1536 |
0.335 |
|
| 2014 |
Federico SM, Stewart E, Bradley C, McEvoy J, Loh A, Shelat A, Zhang J, Chen X, Pappo AS, Dyer MA. Molecular analysis of solid tumors (MAST): A protocol for comprehensive preclinical evaluation of pediatric solid tumors. Journal of Clinical Oncology. 32: 10036-10036. DOI: 10.1200/Jco.2014.32.15_Suppl.10036 |
0.301 |
|
| 2014 |
Dyer MA. Abstract IA05: Targeting the oxidative stress pathway in rhabdomyosarcoma Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-Ia05 |
0.389 |
|
| 2014 |
Wierdl M, Tsurkan L, Tollemar V, Chi L, Stewart E, Dyer MA, Potter PM. Abstract 3109: ALK as a valid therapeutic target for the treatment of rhabdomyosarcoma Cancer Research. 74: 3109-3109. DOI: 10.1158/1538-7445.Am2014-3109 |
0.398 |
|
| 2013 |
Benavente CA, McEvoy JD, Finkelstein D, Wei L, Kang G, Wang YD, Neale G, Ragsdale S, Valentine V, Bahrami A, Temirov J, Pounds S, Zhang J, Dyer MA. Cross-species genomic and epigenomic landscape of retinoblastoma. Oncotarget. 4: 844-59. PMID 23765217 DOI: 10.18632/Oncotarget.1051 |
0.776 |
|
| 2013 |
Cheung NK, Dyer MA. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nature Reviews. Cancer. 13: 397-411. PMID 23702928 DOI: 10.1038/Nrc3526 |
0.334 |
|
| 2012 |
Parker M, Chen X, Bahrami A, Dalton J, Rusch M, Wu G, Easton J, Cheung NK, Dyer M, Mardis ER, Wilson RK, Mullighan C, Gilbertson R, Baker SJ, Zambetti G, et al. Assessing telomeric DNA content in pediatric cancers using whole-genome sequencing data. Genome Biology. 13: R113. PMID 23232254 DOI: 10.1186/Gb-2012-13-12-R113 |
0.335 |
|
| 2012 |
McEvoy J, Ulyanov A, Brennan R, Wu G, Pounds S, Zhang J, Dyer MA. Analysis of MDM2 and MDM4 single nucleotide polymorphisms, mRNA splicing and protein expression in retinoblastoma. Plos One. 7: e42739. PMID 22916154 DOI: 10.1371/Journal.Pone.0042739 |
0.363 |
|
| 2012 |
Nittner D, Lambertz I, Clermont F, Mestdagh P, Köhler C, Nielsen SJ, Jochemsen A, Speleman F, Vandesompele J, Dyer MA, Schramm A, Schulte JH, Marine JC. Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation. Nature Cell Biology. 14: 958-65. PMID 22864477 DOI: 10.1038/ncb2556 |
0.369 |
|
| 2012 |
Cheung NK, Zhang J, Lu C, Parker M, Bahrami A, Tickoo SK, Heguy A, Pappo AS, Federico S, Dalton J, Cheung IY, Ding L, Fulton R, Wang J, Chen X, ... ... Dyer MA, et al. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. Jama. 307: 1062-71. PMID 22416102 DOI: 10.1001/Jama.2012.228 |
0.32 |
|
| 2012 |
Zhang J, Benavente CA, McEvoy J, Flores-Otero J, Ding L, Chen X, Ulyanov A, Wu G, Wilson M, Wang J, Brennan R, Rusch M, Manning AL, Ma J, Easton J, ... ... Dyer MA, et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature. 481: 329-34. PMID 22237022 DOI: 10.1038/Nature10733 |
0.761 |
|
| 2012 |
Federico SM, Stewart E, Brennan RC, Bradley C, Wang F, Freeman BB, Stewart CF, Wu J, Dyer MA. Comprehensive preclinical testing for neuroblastoma using orthotopic xenografts of a patient tumor. Journal of Clinical Oncology. 30: e13584-e13584. DOI: 10.1200/JCO.2012.30.15_SUPPL.E13584 |
0.39 |
|
| 2012 |
Brennan RC, Wilson MW, Dyer MA, Bahrami A. SYK expression in metastatic retinoblastoma. Journal of Clinical Oncology. 30: e13544-e13544. DOI: 10.1200/JCO.2012.30.15_SUPPL.E13544 |
0.386 |
|
| 2012 |
Parker MD, Wu G, Chen X, Rusch M, Bahrami A, Ding L, Mardis E, Mullighan C, Gilbertson R, Dyer MA, Wilson RK, Downing J, Zhang J. Abstract 4873: Comprehensive analysis of 160 whole-genome sequences reveals striking telomere alteration patterns in 9 pediatric cancers Cancer Research. 72: 4873-4873. DOI: 10.1158/1538-7445.Am2012-4873 |
0.355 |
|
| 2012 |
Chen X, Wang J, Roberts K, Pounds S, Dyer M, Mullighan C, Downing J, Zhang J. Abstract 2487: CONSERTING: an accurate method for detecting focal and gross somatic copy number alterations in cancer genome by next generation sequencing Cancer Research. 72: 2487-2487. DOI: 10.1158/1538-7445.Am2012-2487 |
0.332 |
|
| 2011 |
Martins RA, Davis D, Kerekes R, Zhang J, Bayazitov IT, Hiler D, Karakaya M, Frase S, Gleason S, Zakharenko SS, Johnson DA, Dyer MA. Retinoblastoma (Rb) regulates laminar dendritic arbor reorganization in retinal horizontal neurons. Proceedings of the National Academy of Sciences of the United States of America. 108: 21111-6. PMID 22160703 DOI: 10.1073/Pnas.1108141108 |
0.67 |
|
| 2011 |
McEvoy J, Flores-Otero J, Zhang J, Nemeth K, Brennan R, Bradley C, Krafcik F, Rodriguez-Galindo C, Wilson M, Xiong S, Lozano G, Sage J, Fu L, Louhibi L, Trimarchi J, ... ... Dyer MA, et al. Coexpression of normally incompatible developmental pathways in retinoblastoma genesis. Cancer Cell. 20: 260-75. PMID 21840489 DOI: 10.1016/J.Ccr.2011.07.005 |
0.743 |
|
| 2011 |
Teitz T, Stanke JJ, Federico S, Bradley CL, Brennan R, Zhang J, Johnson MD, Sedlacik J, Inoue M, Zhang ZM, Frase S, Rehg JE, Hillenbrand CM, Finkelstein D, Calabrese C, ... Dyer MA, et al. Preclinical models for neuroblastoma: establishing a baseline for treatment. Plos One. 6: e19133. PMID 21559450 DOI: 10.1371/journal.pone.0019133 |
0.405 |
|
| 2011 |
Federico S, Brennan R, Dyer MA. Childhood cancer and developmental biology a crucial partnership. Current Topics in Developmental Biology. 94: 1-13. PMID 21295682 DOI: 10.1016/B978-0-12-380916-2.00001-2 |
0.381 |
|
| 2011 |
Kerekes RA, Martins RA, Davis D, Karakaya M, Gleason S, Dyer MA. Automated tracing of horizontal neuron processes during retinal development. Neurochemical Research. 36: 583-93. PMID 21221777 DOI: 10.1007/S11064-010-0390-1 |
0.627 |
|
| 2011 |
Nemeth KM, Federico S, Carcaboso AM, Shen Y, Schaiquevich P, Zhang J, Egorin M, Stewart C, Dyer MA. Subconjunctival carboplatin and systemic topotecan treatment in preclinical models of retinoblastoma. Cancer. 117: 421-34. PMID 20818652 DOI: 10.1002/Cncr.25574 |
0.311 |
|
| 2011 |
Dyer MA. Abstract SY15-02: Comprehensive analysis of genetic and epigenetic factors contributing to tumorigenesis in retinoblastoma Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Sy15-02 |
0.401 |
|
| 2011 |
Benavente CA, Dyer MA. Abstract A163: A role for epigenetic reprogramming in retinoblastoma tumorigenesis. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-A163 |
0.44 |
|
| 2010 |
Davis DM, Dyer MA. Retinal progenitor cells, differentiation, and barriers to cell cycle reentry. Current Topics in Developmental Biology. 93: 175-88. PMID 20959166 DOI: 10.1016/B978-0-12-385044-7.00006-0 |
0.456 |
|
| 2010 |
Reed D, Shen Y, Shelat AA, Arnold LA, Ferreira AM, Zhu F, Mills N, Smithson DC, Regni CA, Bashford D, Cicero SA, Schulman BA, Jochemsen AG, Guy RK, Dyer MA. Identification and characterization of the first small molecule inhibitor of MDMX. The Journal of Biological Chemistry. 285: 10786-96. PMID 20080970 DOI: 10.1074/Jbc.M109.056747 |
0.694 |
|
| 2009 |
Laurie N, Mohan A, McEvoy J, Reed D, Zhang J, Schweers B, Ajioka I, Valentine V, Johnson D, Ellison D, Dyer MA. Changes in retinoblastoma cell adhesion associated with optic nerve invasion. Molecular and Cellular Biology. 29: 6268-82. PMID 19786571 DOI: 10.1128/Mcb.00374-09 |
0.694 |
|
| 2009 |
Dyer MA. In their own words: interviews with Cell Cycle. The first knockout mouse model of retinoblastoma. Cell Cycle (Georgetown, Tex.). 8: 2145. PMID 19574732 DOI: 10.4161/CC.8.14.9068 |
0.328 |
|
| 2009 |
Dyer MA, Martins R, da Silva Filho M, Muniz JA, Silveira LC, Cepko CL, Finlay BL. Developmental sources of conservation and variation in the evolution of the primate eye. Proceedings of the National Academy of Sciences of the United States of America. 106: 8963-8. PMID 19451636 DOI: 10.1073/Pnas.0901484106 |
0.738 |
|
| 2009 |
Cicero SA, Johnson D, Reyntjens S, Frase S, Connell S, Chow LM, Baker SJ, Sorrentino BP, Dyer MA. Cells previously identified as retinal stem cells are pigmented ciliary epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 6685-90. PMID 19346468 DOI: 10.1073/Pnas.0901596106 |
0.735 |
|
| 2009 |
Shih CS, Laurie N, Holzmacher J, Spence Y, Nathwani AC, Davidoff AM, Dyer MA. AAV-mediated local delivery of interferon-beta for the treatment of retinoblastoma in preclinical models. Neuromolecular Medicine. 11: 43-52. PMID 19306089 DOI: 10.1007/s12017-009-8059-0 |
0.647 |
|
| 2009 |
Ajioka I, McEvoy J, Nakajima K, Dyer M. The role of the Rb family during mouse retinal development Neuroscience Research. 65. DOI: 10.1016/J.Neures.2009.09.139 |
0.347 |
|
| 2008 |
Dyer M. Special issue on retinal development Brain Research. 1192: 1-2. PMID 18261521 DOI: 10.1016/j.brainres.2008.01.001 |
0.358 |
|
| 2008 |
Ajioka I, Dyer MA. A new model of tumor susceptibility following tumor suppressor gene inactivation. Cell Cycle (Georgetown, Tex.). 7: 735-40. PMID 18239449 DOI: 10.4161/Cc.7.6.5612 |
0.445 |
|
| 2008 |
Martins RA, Zindy F, Donovan S, Zhang J, Pounds S, Wey A, Knoepfler PS, Eisenman RN, Roussel MF, Dyer MA. N-myc coordinates retinal growth with eye size during mouse development. Genes & Development. 22: 179-93. PMID 18198336 DOI: 10.1101/Gad.1608008 |
0.656 |
|
| 2008 |
Pounds S, Dyer MA. Statistical analysis of data from retroviral clonal experiments in the developing retina. Brain Research. 1192: 178-85. PMID 17950704 DOI: 10.1016/j.brainres.2007.08.074 |
0.464 |
|
| 2008 |
Laurie NA, Dyer MA, Shih CS. Targeting MDM2 and MDMX in retinoblastoma (Current Cancer Drug Targets (2007) 7, 7, (689-695)) Current Cancer Drug Targets. 8: 341. DOI: 10.2174/156800908784533472 |
0.633 |
|
| 2007 |
Laurie NA, Shih CS, Schin-Shih C, Dyer MA. Targeting MDM2 and MDMX in retinoblastoma. Current Cancer Drug Targets. 7: 689-95. PMID 18045074 DOI: 10.2174/156800907782418266 |
0.679 |
|
| 2007 |
Ajioka I, Martins RA, Bayazitov IT, Donovan S, Johnson DA, Frase S, Cicero SA, Boyd K, Zakharenko SS, Dyer MA. Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell. 131: 378-90. PMID 17956737 DOI: 10.1016/J.Cell.2007.09.036 |
0.764 |
|
| 2007 |
MacPherson D, Dyer MA. Retinoblastoma: from the two-hit hypothesis to targeted chemotherapy. Cancer Research. 67: 7547-50. PMID 17699756 DOI: 10.1158/0008-5472.CAN-07-0276 |
0.359 |
|
| 2007 |
Besson A, Hwang HC, Cicero S, Donovan SL, Gurian-West M, Johnson D, Clurman BE, Dyer MA, Roberts JM. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes & Development. 21: 1731-46. PMID 17626791 DOI: 10.1101/Gad.1556607 |
0.721 |
|
| 2007 |
Johnson DA, Zhang J, Frase S, Wilson M, Rodriguez-Galindo C, Dyer MA. Neuronal differentiation and synaptogenesis in retinoblastoma. Cancer Research. 67: 2701-11. PMID 17363591 DOI: 10.1158/0008-5472.CAN-06-3754 |
0.462 |
|
| 2007 |
Marine JC, Dyer MA, Jochemsen AG. MDMX: from bench to bedside. Journal of Cell Science. 120: 371-8. PMID 17251377 DOI: 10.1242/jcs.03362 |
0.357 |
|
| 2006 |
Donovan SL, Dyer MA. Preparation and square wave electroporation of retinal explant cultures. Nature Protocols. 1: 2710-8. PMID 17406527 DOI: 10.1038/Nprot.2006.454 |
0.365 |
|
| 2006 |
Laurie NA, Donovan SL, Shih CS, Zhang J, Mills N, Fuller C, Teunisse A, Lam S, Ramos Y, Mohan A, Johnson D, Wilson M, Rodriguez-Galindo C, Quarto M, Francoz S, ... ... Dyer MA, et al. Inactivation of the p53 pathway in retinoblastoma. Nature. 444: 61-6. PMID 17080083 DOI: 10.1038/Nature05194 |
0.711 |
|
| 2006 |
Martins RA, Linden R, Dyer MA. Glutamate regulates retinal progenitors cells proliferation during development. The European Journal of Neuroscience. 24: 969-80. PMID 16925590 DOI: 10.1111/J.1460-9568.2006.04966.X |
0.721 |
|
| 2006 |
Johnson DA, Donovan SL, Dyer MA. Mosaic deletion of Rb arrests rod differentiation and stimulates ectopic synaptogenesis in the mouse retina. The Journal of Comparative Neurology. 498: 112-28. PMID 16856163 DOI: 10.1002/Cne.21059 |
0.429 |
|
| 2006 |
Donovan SL, Schweers B, Martins R, Johnson D, Dyer MA. Compensation by tumor suppressor genes during retinal development in mice and humans. Bmc Biology. 4: 14. PMID 16672052 DOI: 10.1186/1741-7007-4-14 |
0.685 |
|
| 2006 |
Sun H, Chang Y, Schweers B, Dyer MA, Zhang X, Hayward SW, Goodrich DW. An E2F binding-deficient Rb1 protein partially rescues developmental defects associated with Rb1 nullizygosity. Molecular and Cellular Biology. 26: 1527-37. PMID 16449662 DOI: 10.1128/Mcb.26.4.1527-1537.2006 |
0.412 |
|
| 2005 |
Schweers BA, Dyer MA. Perspective: new genetic tools for studying retinal development and disease. Visual Neuroscience. 22: 553-60. PMID 16332265 DOI: 10.1017/S0952523805225026 |
0.428 |
|
| 2005 |
Laurie NA, Gray JK, Zhang J, Leggas M, Relling M, Egorin M, Stewart C, Dyer MA. Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 7569-78. PMID 16243833 DOI: 10.1158/1078-0432.Ccr-05-0849 |
0.689 |
|
| 2005 |
Donovan SL, Dyer MA. Regulation of proliferation during central nervous system development. Seminars in Cell & Developmental Biology. 16: 407-21. PMID 15840449 DOI: 10.1016/J.Semcdb.2005.02.012 |
0.424 |
|
| 2005 |
Dyer MA, Bremner R. The search for the retinoblastoma cell of origin. Nature Reviews. Cancer. 5: 91-101. PMID 15685194 DOI: 10.1038/nrc1545 |
0.442 |
|
| 2004 |
Dyer MA, Donovan SL, Zhang J, Gray J, Ortiz A, Tenney R, Kong J, Allikmets R, Sohocki MM. Retinal degeneration in Aipl1-deficient mice: a new genetic model of Leber congenital amaurosis. Brain Research. Molecular Brain Research. 132: 208-20. PMID 15582159 DOI: 10.1016/J.Molbrainres.2004.10.011 |
0.47 |
|
| 2004 |
Donovan SL, Dyer MA. Developmental defects in Rb-deficient retinae. Vision Research. 44: 3323-33. PMID 15536000 DOI: 10.1016/J.Visres.2004.08.007 |
0.464 |
|
| 2004 |
Zhang J, Schweers B, Dyer MA. The first knockout mouse model of retinoblastoma. Cell Cycle (Georgetown, Tex.). 3: 952-9. PMID 15190215 DOI: 10.4161/Cc.3.7.1002 |
0.336 |
|
| 2004 |
Dyer MA. Mouse models of childhood cancer of the nervous system. Journal of Clinical Pathology. 57: 561-76. PMID 15166259 DOI: 10.1136/jcp.2003.009910 |
0.404 |
|
| 2004 |
Zhang J, Gray J, Wu L, Leone G, Rowan S, Cepko CL, Zhu X, Craft CM, Dyer MA. Rb regulates proliferation and rod photoreceptor development in the mouse retina. Nature Genetics. 36: 351-60. PMID 14991054 DOI: 10.1038/Ng1318 |
0.766 |
|
| 2004 |
Baron MH, Willey S, Sahr K, Zhang H, Balbi K, Dyer MA, Adlam M. Induction and Patterning of Pre-Hemato-Vascular Mesoderm by the Mouse Mix Homeodomain Protein. Blood. 104: 565-565. DOI: 10.1182/blood.v104.11.565.565 |
0.402 |
|
| 2003 |
Dyer MA. Regulation of proliferation, cell fate specification and differentiation by the homeodomain proteins Prox1, Six3, and Chx10 in the developing retina. Cell Cycle (Georgetown, Tex.). 2: 350-7. PMID 12851489 |
0.37 |
|
| 2003 |
Dyer MA, Livesey FJ, Cepko CL, Oliver G. Prox1 function controls progenitor cell proliferation and horizontal cell genesis in the mammalian retina. Nature Genetics. 34: 53-8. PMID 12692551 DOI: 10.1038/ng1144 |
0.742 |
|
| 2003 |
Dyer MA. The Homeodomain Proteins Prox1, Six3 and Chx10 Regulate Proliferation, Cell Fate Specification and Differentiation in the Developing Retina Cell Cycle. 2: 347-354. DOI: 10.4161/cc.2.4.429 |
0.467 |
|
| 2003 |
Akey DT, Zhu X, Dyer M, Li A, Sorensen A, Fukada-Kamitani T, Daiger SP, Craft C, Kamitani T, Sohocki MM. Functional Studies of AIPL1 Advances in Experimental Medicine and Biology. 533: 287-295. DOI: 10.1007/978-1-4615-0067-4_35 |
0.323 |
|
| 2002 |
Akey DT, Zhu X, Dyer M, Li A, Sorensen A, Blackshaw S, Fukuda-Kamitani T, Daiger SP, Craft CM, Kamitani T, Sohocki MM. The inherited blindness associated protein AIPL1 interacts with the cell cycle regulator protein NUB1. Human Molecular Genetics. 11: 2723-33. PMID 12374762 DOI: 10.1093/HMG/11.22.2723 |
0.631 |
|
| 2001 |
Dyer MA, Cepko CL. p27Kip1 and p57Kip2 regulate proliferation in distinct retinal progenitor cell populations. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 4259-71. PMID 11404411 DOI: 10.1523/Jneurosci.21-12-04259.2001 |
0.6 |
|
| 2001 |
Dyer MA, Cepko CL. Regulating proliferation during retinal development. Nature Reviews. Neuroscience. 2: 333-42. PMID 11331917 DOI: 10.1038/35072555 |
0.571 |
|
| 2001 |
Dyer MA, Cepko CL. The p57Kip2 cyclin kinase inhibitor is expressed by a restricted set of amacrine cells in the rodent retina. The Journal of Comparative Neurology. 429: 601-14. PMID 11135238 DOI: 10.1002/1096-9861(20010122)429:4<601::AID-CNE7>3.0.CO;2-V |
0.565 |
|
| 2000 |
Dyer MA, Cepko CL. Control of Müller glial cell proliferation and activation following retinal injury. Nature Neuroscience. 3: 873-80. PMID 10966617 DOI: 10.1038/78774 |
0.595 |
|
| 2000 |
Dyer MA, Cepko CL. p57(Kip2) regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina. Development (Cambridge, England). 127: 3593-605. PMID 10903183 |
0.599 |
|
| Show low-probability matches. |